Membrane innovation: closer to native kidneys
- PMID: 30281130
- PMCID: PMC6168921
- DOI: 10.1093/ndt/gfy228
Membrane innovation: closer to native kidneys
Abstract
Modern methods in analytical biochemistry have established that uraemia is associated with the retention of proteins, both in their native state and post-translationally modified, over a wide range of molecular weights up to 60 kDa. Evidence is accumulating that these higher molecular weight retention solutes are important uraemic toxins, and therapies such as online haemodiafiltration (HDF), which enhance their removal, are associated with improved outcomes. However, HDF has limitations regarding cost, clinical implementation and the need for an external source of sterile substitution solution to maintain fluid balance. New membranes that have a solute removal profile more closely approaching that of the glomerular filtration barrier when used for conventional haemodialysis, while at the same time not allowing the passage of clinically significant amounts of beneficial proteins, are needed to address these limitations. Tighter control of the molecular characteristics of the polymers used for membrane fabrication, along with the introduction of additives and improvements in the manufacturing process, has led to membranes with a tighter pore size distribution that allows the use of an increased absolute pore size without leaking substantial amounts of albumin. At the same time, the wall thickness and internal diameter of membrane fibres have been decreased, enhancing convective transport within the dialyser without the need for an external source of substitution solution. These new expanded range membranes provide a solute removal profile more like that of the native kidney than currently available membranes when used in conventional haemodialysis.
Figures
References
-
- Babb AL, Popovich RP, Christopher TG. et al. The genesis of the square meter-hour hypothesis. Trans Am Soc Artif Intern Organs 1971; 17: 81–91 - PubMed
-
- Fürst P, Zimmerman L, Bergström J.. Determination of endogenous middle molecules in normal and uremic body fluids. Clin Nephrol 1976; 3: 178–188 - PubMed
-
- Gejyo F, Odani S, Yamada T. et al. β2-microglobulin: a new form of amyloid protein associated with chronic hemodialysis. Kidney Int 1986; 30: 385–390 - PubMed
-
- Cohen G, Haag-Weber M, Mai B. et al. Effect of immunoglobulin light chains from hemodialysis and continuous ambulatory peritoneal dialysis patients on polymorphonuclear leukocyte functions. J Am Soc Nephrol 1995; 6: 1592–1599 - PubMed
-
- Deppisch RM, Beck W, Goehl H. et al. Complement components as uremic toxins and their potential role as mediators of microinflammation. Kidney Int 2001; 59(Suppl 78): S271–S277 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
